SCHEMBL7352871

SCHEMBL7352871

CCC(c1ccc(OC(C)=O)cc1)c1c(O)c2ccccc2oc1=O

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 9/20 0.73
ALB P02768 2/20 0.62
VKORC1 Q9BQB6 2/20 0.62
KDM4E B2RXH2 1/20 0.62
ALDH1A1 P00352 1/20 0.62
PCSK7 Q16549 1/20 0.62
HSD17B10 Q99714 1/20 0.62
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
NQO1 P15559 2/20 0.58
ADORA3 P0DMS8 1/20 0.56
NR1I2 O75469 1/20 0.55
NR3C1 P04150 1/20 0.55
ADRA1A P35348 1/20 0.55
KCNH2 Q12809 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9204503 1.00 CYP2C9 (0.73) CYP2C9ALBVKORC1KDM4EALDH1A1
SCHEMBL7353207 0.87 CYP2C9 (0.79) CYP2C9ALBVKORC1KDM4EALDH1A1
Phenprocoumon SCHEMBL24500472 0.85 CYP2C9 (1.00) CYP2C9ALBVKORC1KDM4EALDH1A1
Phenprocoumon SCHEMBL29392123 0.85 CYP2C9 (1.00) CYP2C9ALBVKORC1KDM4EALDH1A1
Phenprocoumon SCHEMBL43031 0.85 CYP2C9 (1.00) CYP2C9ALBVKORC1KDM4EALDH1A1
Phenprocoumon SCHEMBL24500477 0.85 CYP2C9 (1.00) CYP2C9ALBVKORC1KDM4EALDH1A1
SCHEMBL7351110 0.84 CYP2C9 (0.87) CYP2C9ALBVKORC1KDM4EALDH1A1
SCHEMBL7356919 0.84 CYP2C9 (0.65) CYP2C9ALBVKORC1KDM4EALDH1A1
SCHEMBL9205338 0.84 CYP2C9 (0.65) CYP2C9ALBVKORC1KDM4EALDH1A1
Warfarin SCHEMBL13724154 0.82 CYP2C9 (0.90) CYP2C9ALBVKORC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 EP claimed
US-5686486-A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1997-11-11 US claimed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 EP claimed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 WO claimed
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 EP disclosed
US-5686486-A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1997-11-11 US disclosed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 EP disclosed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 WO disclosed